Most Popular Stories
- CMS investigates hospital for harsh collections, EMTALA violation
- Temple, doc pay $1M to settle fraud claims
- Ex-hospital VP pleads guilty to bribery, kickbacks, theft
- Kinect works toward degree in early autism diagnosis
- Joplin hospitals share lessons on disaster planning
- High-volume hospitals are more costly for all patients
Events
- IHI's New 12-Month Triple Aim Improvement Community - Free informational calls
May 31 & June 12 - Webcast: Engaging Patients as Consumers
Tuesday May 22nd 4:00 pm ET - Northwestern Online Master of Science in Medical Informatics Program
- 2nd Annual Medicare Advantage Compliance Symposium
May 31, 2012 — Washington Plaza Hotel, Washington, DC
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
Free Newsletter
FierceHealthPayer provides the latest news about the fast-changing and heavily regulated area of healthcare reimbursement. Join 16,000 healthcare plan executives who get FierceHealthPayer via twice weekly email. Sign up today!
Top Tags
Unnecessary tests cost $6.8B in care
Unnecessary tests ordered by physicians led to at least $6.8 billion worth of misplaced health spending, reports FiercePracticeManagement. A new study led by physicians from the Mount Sinai Medical Center and the Weill Cornell Medical College in New York examined the cost of common medical practices that a work group of internists, family physicians, and pediatricians identified as being overused. According to the study, some of the most costly and common sources of misplaced health spending include complete blood cell count ordered at a routine physical exam, brand-name statins ordered before trying a generic drug first (accounting for $5.8 billion of the $6.8 billion total), blood and diagnostic tests ordered for patients with no related symptoms or risk factors, prescriptions for antibiotics for children without strep, and brain imaging on children who had fallen but displayed no signs of concussion. --Read the full post at FiercePracticeManagement
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| EditorsTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceCRO | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2012 FierceMarkets. All rights reserved. |
![]() |
